Loading...

InMed Pharmaceuticals Inc.

INM•NASDAQ
Healthcare
Biotechnology
$1.60
$0.92(135.05%)
U.S. Market opens in 9h 33m

InMed Pharmaceuticals Inc. (INM) Stock Overview

Explore InMed Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8M
P/E Ratio-0.64
EPS (TTM)$-1.47
ROE-0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$0.13
3 Months$0.00
1 Year Target$3.31

INM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of InMed Pharmaceuticals Inc. (INM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 86.42, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $3.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.64 and a market capitalization of 2.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
127.71%
5-Day Change
128.71%
1-Month Change
118.31%
3-Month Change
80.23%
6-Month Change
26.02%
Year-to-Date (YTD) Change
46.23%
1-Year Change
-43.84%
3-Year Change
-94.34%
5-Year Change
-99.88%
All-Time (Max) Change
-99.96%

Contact Information

https://www.inmedpharma.com
604 669 7207
815 West Hastings Street, Vancouver, BC, V6C 1B4

Company Facts

13 Employees
IPO DateMay 5, 2014
CountryCA
Actively Trading

Frequently Asked Questions